Repurposing Salicylamide for Combating Multidrug-Resistant Neisseria gonorrhoeae
Author(s) -
Marwa Alhashimi,
Abdelrahman S. Mayhoub,
Mohamed N. Seleem
Publication year - 2019
Publication title -
antimicrobial agents and chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.07
H-Index - 259
eISSN - 1070-6283
pISSN - 0066-4804
DOI - 10.1128/aac.01225-19
Subject(s) - neisseria gonorrhoeae , salicylamide , microbiology and biotechnology , ceftriaxone , gonorrhea , pharmacology , antibiotics , drug resistance , medicine , biology , virology , psychiatry , human immunodeficiency virus (hiv)
The U.S. Centers for Disease Control and Prevention (CDC) listsNeisseria gonorrhoeae as one of the most urgent antibiotic-resistant threats in the United States. This is due to the emergence of clinical isolates that have developed resistance to nearly every antibiotic used to treat gonorrhea and highlights the critical need to find new therapeutics.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom